01 15GLENMARK SPECLT
02 7INTERSECT ENT INC
01 17544192
02 18025635
03 18763222
04 19078923
05 19370483
06 19585681
07 19750754
08 19937189
09 110016443
10 110232152
11 110357640
12 110376526
13 110406332
14 110517880
15 110548907
16 110561672
17 110646500
18 110758550
19 110765686
20 111400101
21 111679210
22 112064442
01 22Blank
01 12Y
02 10Blank
01 12026-04-04
02 12026-11-29
03 12027-06-12
04 12031-10-03
05 12032-02-08
06 12034-03-13
07 142034-09-04
08 12034-11-24
09 12038-09-03
Patent Expiration Date : 2027-06-12
US Patent Number : 8025635
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209310
Patent Use Code : U-2272
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-12
Patent Expiration Date : 2034-11-24
US Patent Number : 10232152
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209310
Patent Use Code : U-2272
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-11-24
Patent Expiration Date : 2031-10-03
US Patent Number : 10357640
Drug Substance Claim :
Drug Product Claim :
Application Number : 209310
Patent Use Code : U-2272
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-10-03
Patent Expiration Date : 2026-04-04
US Patent Number : 9585681
Drug Substance Claim :
Drug Product Claim :
Application Number : 209310
Patent Use Code : U-2272
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-04-04
Patent Expiration Date : 2026-11-29
US Patent Number : 7544192
Drug Substance Claim :
Drug Product Claim :
Application Number : 209310
Patent Use Code : U-2272
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-11-29
Patent Expiration Date : 2034-03-13
US Patent Number : 10406332
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209310
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-13
Patent Expiration Date : 2032-02-08
US Patent Number : 8763222
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209310
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-02-08
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10765686
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3295
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10758550
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3296
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-04
MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE
US Patent Number : 10646500
Drug Substance Claim :
Drug Product Claim :
Application Number : 211746
Patent Use Code : U-3297
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-09-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
